Role of tumor-associated, phosphorylated glycoprotein-membrane-antigen in bovine leukemia virus-induced lymphosarcoma.
肿瘤相关磷酸化糖蛋白膜抗原在牛白血病病毒诱导的淋巴肉瘤中的作用。
基本信息
- 批准号:05404016
- 负责人:
- 金额:$ 16.7万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Bovine leukemia virus (BLV) is associated with enzootic bovine leukosis (EBL), which is the most common neoplastic disease of cattle. To clarify the way in which BLV-infected cattle progress from the asymptomatic stage to the lymphoma stage, we produced a monoclonal antibody (Mab) c143 which recognized a tumor-associated antigen (TAA) that is phosphorylated in the transformed state of BLV-infected B-lymphoid cells. The TAA was mainly expressed on B-cells, macrophages, reticular cells, and a minor population of BoCD4-positive T-cells in BLV-free normal cattle. Since the nature of c143 TAA was likely to be that of the major histocompatibility complex (MHC) class II antigens, we isolated cDNAs for bovine MHC (BoLA) class alpha-chains (36-37 kD) and beta-chains (32 and 34 kD), produced transfectants that expressed a single type of BoLA class II molecules and analyzed them by flow cytometry with c143 Mab. The c143 Mab recognized the transfectant expressing BoLA-DR but not BoLA-DQ.However, the treatment of lymphocytes with c143 or anti-BoLA-DR Mab induced different effects. Although mixed lymphocyte reaction (MLR) was inhibited by the addition of anti-BoLA-DR Mab, the c143 Mab did not inhibit a proliferative response of T cells in MLR.Increased spontaneous proliferation of lymphocytes in healthy donors was obtained in the presence of c143 Mab but not anti-BoLA-DR Mab, and was much in lymphocytes from the carrier. More over, the patterns of immunohistological staining for c143 Mab in BLV-infected sheep showed distinguishing differences from those of anti-BoLA-DR Mabs.An immunohistochemical examination using c143 Mab as tumor marker for identification of EBL indicated that the bovine leukemia virus-transformed lymphocytes or neoplastic cells in peripheral blood accumulate in the marginal sinus area at the earliest stages, and subsequently proliferate and infiltrate into follicles, leading to the development of clinical signs of lymphosarcoma.
牛白血病病毒(BLV)与牛牛白细胞病(EBL)有关,这是牛最常见的肿瘤疾病。为了阐明BLV感染的牛从无症状阶段到淋巴瘤阶段的发展方式,我们产生了一种单克隆抗体(MAB)C143,该抗体C143识别出肿瘤相关的抗原(TAA),该抗原(TaA)在BLV感染的B-淋巴细胞转化状态下磷酸化。 TAA主要以B细胞,巨噬细胞,网状细胞和少量的BOCD4阳性T细胞在无BLV的正常牛中表达。 Since the nature of c143 TAA was likely to be that of the major histocompatibility complex (MHC) class II antigens, we isolated cDNAs for bovine MHC (BoLA) class alpha-chains (36-37 kD) and beta-chains (32 and 34 kD), produced transfectants that expressed a single type of BoLA class II molecules and analyzed them by flow cytometry with C143 mab。 C143 mAb识别表达bola-dr但不表达bola-dq的转染剂。 Although mixed lymphocyte reaction (MLR) was inhibited by the addition of anti-BoLA-DR Mab, the c143 Mab did not inhibit a proliferative response of T cells in MLR.Increased spontaneous proliferation of lymphocytes in healthy donors was obtained in the presence of c143 Mab but not anti-BoLA-DR Mab, and was much in lymphocytes from the 载体。 More over, the patterns of immunohistological staining for c143 Mab in BLV-infected sheep showed distinguishing differences from those of anti-BoLA-DR Mabs.An immunohistochemical examination using c143 Mab as tumor marker for identification of EBL indicated that the bovine leukemia virus-transformed lymphocytes or neoplastic cells in peripheral blood accumulate in the marginal鼻窦区域最早的阶段,随后扩散并浸润到卵泡中,导致淋巴瘤临床体征的发展。
项目成果
期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tani K., M.Asahina, D.Wu, T.Ajito, K.Murakami, M.Goryo, Y.Aida, W.C.Davis and K.Okada.: "Further analysis of the phenotype and distribution of B-cell and T-cell lymphomas in the lymph node and spleen of cattle." Vet.Pathol.(in press). (1997)
Tani K.、M.Asahina、D.Wu、T.Ajito、K.Murakami、M.Goryo、Y.Aida、W.C.Davis 和 K.Okada.:“B 细胞和 T 细胞表型和分布的进一步分析
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Koguchi, A., T.Chiba, M.Hiraga, T.Hasuta, T.Tsujimoto, K.Furusato, M.Goryo, W.C.Davis, Y.Aida and K.Okada.: "Changes in the distribution of cells expressing tumor-associated antigen in lymph nodes during the progression of enzootic bovine leukosis." J.Com
Koguchi, A., T.Chiba, M.Hiraga, T.Hasuta, T.Tsujimoto, K.Furusato, M.Goryo, W.C.Davis, Y.Aida 和 K.Okada.:“表达肿瘤的细胞分布的变化
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okada, K., S.Ikeyama, K.Ohishi, H.Suzuki, M.Sugimoto, S.Numakunai, T.Chiba, K.Murakami, W.C.Davis, K.Ohshima and Y.Ikawa.: "Involvement of CD8+ T Cells in delayd-type hypersensitivity responses against bovine leukemia virus (BLV) induced in sheep vaccinat
Okada, K., S.Ikeyama, K.Ohishi, H.Suzuki, M.Sugimoto, S.Numakunai, T.Chiba, K.Murakami, W.C.Davis, K.Ohshima 和 Y.Ikawa.:“CD8 T 的参与
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
岡田幸助: "牛白血病、「感染症カラーアトラス」、" 見上 彪、丸山 努監修、文永堂出版, 200 (1997)
Kosuke Okada:“牛白血病,‘传染病彩色图谱’,由 Takashi Migami 和 Tsutomu Maruyama 监督,Buneido Publishing,200 (1997)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Slavikova,K.,et al.: "gp51 of bovine leukemia virus gene expression in hamster cells." Int.J.Cancer. 53. 640-644 (1993)
Slavikova,K.,et al.:“仓鼠细胞中牛白血病病毒基因表达的 gp51。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKADA Kosuke其他文献
OKADA Kosuke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKADA Kosuke', 18)}}的其他基金
The mechanism of liver carcinogenesis in NASH from the view point of organ crosstalk using tissue specific conditional rescue mice
使用组织特异性条件救援小鼠从器官串扰的角度探讨 NASH 肝癌发生机制
- 批准号:
18K07930 - 财政年份:2018
- 资助金额:
$ 16.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Search of developmental and inhibitory factors in pathogenesis of enzootic bovine leukosis
牛地方性白血病发病机制中发育及抑制因素的探索
- 批准号:
13460138 - 财政年份:2001
- 资助金额:
$ 16.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Fundamental study on mineral metabolism in race horses with bone fracture
骨折赛马矿物质代谢的基础研究
- 批准号:
61440021 - 财政年份:1986
- 资助金额:
$ 16.7万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
相似国自然基金
肿瘤相关糖类抗原Tn促结直肠癌发生和转移的分子机制及干预研究
- 批准号:82372989
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
色氨酸代谢诱导抗原提呈型肿瘤相关成纤维细胞分化促进胃癌免疫激活的机制研究
- 批准号:82372874
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
γδT细胞识别的肿瘤相关膜异位抗原的筛选验证,机制探究及以其为靶点的新型基因工程γδT细胞的疗效评价
- 批准号:32270915
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
γδT细胞识别的肿瘤相关膜异位抗原的筛选验证,机制探究及以其为靶点的新型基因工程γδT细胞的疗效评价
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
EB病毒特异性CD19嵌合抗原受体T(CART)细胞双重靶向治疗EBV相关B细胞肿瘤的作用及机制研究
- 批准号:
- 批准年份:2020
- 资助金额:272 万元
- 项目类别:
相似海外基金
Project 4:Targeting M2-like Macrophages and MDSC with Myelolytic-Virotherapy
项目 4:利用溶髓病毒疗法靶向 M2 样巨噬细胞和 MDSC
- 批准号:
10885260 - 财政年份:2023
- 资助金额:
$ 16.7万 - 项目类别:
Project 4:Targeting M2-like Macrophages and MDSC with Myelolytic-Virotherapy
项目 4:利用溶髓病毒疗法靶向 M2 样巨噬细胞和 MDSC
- 批准号:
10885263 - 财政年份:2023
- 资助金额:
$ 16.7万 - 项目类别:
Leveraging B cell specificities for tumor glycans to elicit potent anti-tumor immunity
利用 B 细胞对肿瘤聚糖的特异性来引发有效的抗肿瘤免疫
- 批准号:
10502322 - 财政年份:2022
- 资助金额:
$ 16.7万 - 项目类别:
Leveraging B cell specificities for tumor glycans to elicit potent anti-tumor immunity
利用 B 细胞对肿瘤聚糖的特异性来引发有效的抗肿瘤免疫
- 批准号:
10662537 - 财政年份:2022
- 资助金额:
$ 16.7万 - 项目类别:
Novel Protein Engineered Drug Conjugates Targeting Phosphatidylserine for the Treatment of Breast Cancer
靶向磷脂酰丝氨酸的新型蛋白质工程药物缀合物用于治疗乳腺癌
- 批准号:
10653821 - 财政年份:2020
- 资助金额:
$ 16.7万 - 项目类别: